PHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS)
Author
Rizo, A.
Kussick, S. J.
Mulligan, G.
Leonard, J. P.
Ferhanoglu, B.
Offner, F.
Reeves, J. A.
Eom, H. S.
Doner, K.
Raposo, J.
Flinn, I. W.
Suh, C.
Chowhan, N. M.
Prasad, S.
Metadata
Show full item recordCollections
- Bildiri [64839]